| Literature DB >> 31036890 |
Dale J Waterhouse1,2, Catherine R M Fitzpatrick2,3, Brian W Pogue4, James P B O'Connor5, Sarah E Bohndiek6,7.
Abstract
Clinical workflows for the non-invasive detection and characterization of disease states could benefit from optical-imaging biomarkers. In this Perspective, we discuss opportunities and challenges towards the clinical implementation of optical-imaging biomarkers for the early detection of cancer by analysing two case studies: the assessment of skin lesions in primary care, and the surveillance of patients with Barrett's oesophagus in specialist care. We stress the importance of technical and biological validations and clinical-utility assessments, and the need to address implementation bottlenecks. In addition, we define a translational roadmap for the widespread clinical implementation of optical-imaging technologies.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31036890 DOI: 10.1038/s41551-019-0392-5
Source DB: PubMed Journal: Nat Biomed Eng ISSN: 2157-846X Impact factor: 29.234